Pamela Villacorta-Landeo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Pamela Villacorta-Landeo has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Ana Brañez-Condorena
EviSalud—Evidencias en Salud, Lima, Perú
2 shared publications - Adelina Lozano Miranda
Hospital Nacional Arzobispo Loayza, Lima, Peru
1 shared publication - Antonio Bernabe-Ortiz
CRONICAS Centre of Excellence in Chronic Diseases Universidad Peruana Cayetano Heredia Lima Peru
1 shared publication - Darwin Del Castillo
CRONICAS Centre of Excellence in Chronic Diseases, Universidad Peruana Cayetano Heredia , Miraflores, Lima 15074
1 shared publication - David García-Gomero
Facultad de Medicina “San Fernando” Universidad Nacional Mayor de San Marcos Lima Peru
1 shared publication - Diana Urday-Ipanaqué
Hospital Nacional Arzobispo Loayza, Lima, Peru
1 shared publication
Latest Publications
- Open Access
Association between maternal depression and the nutritional status of children under five-years-old in Peru: An analysis of the Demographic and Health Survey 2014-2017
Summary: Objective: To evaluate the association between maternal depression and nutritional status of children under 5 years old in Peru. Design: Cross-sectional study of the Demographic and Health Survey 2014-2017. Outcomes were mild (height Z-score for age <-2 SD) and moderate/severe (<-3DE) childhood chronic undernutrition and also mild (hemoglobin <11 g/dL) and moderate/severe (hemoglobin <10 g/dL) childhood anemia. Maternal depression was assessed by the questionnaire PHQ-9. Odds ratios and their confidence intervals (CIs) were estimated by multinomial logistic regression models, considering the complex sample design. Setting: Peru Participants: Peruvian women of childbearing age from 15 to 49 years who live with children from 6 to 59 months. Results: Maternal depression was significantly associated with a higher odds of moderate/severe chronic undernutrition in children aged 6-59 months (OR = 2.67; 95% CI 1.16-6.16). Conclusions: There was evidence that maternal depression was associated with an increased risk of moderate/severe chronic undernutrition
Open AccessAssociation between maternal depression and the nutritional status of children under five-years-old in Peru: An analysis of the Demographic and Health Survey 2014-2017
Summary: Objective: To evaluate the association between maternal depression and nutritional status of children under 5 years old in Peru. Design: Cross-sectional study of the Demographic and Health Survey 2014-2017. Outcomes were mild (height Z-score for age <-2 SD) and moderate/severe (<-3DE) childhood chronic undernutrition and also mild (hemoglobin <11 g/dL) and moderate/severe (hemoglobin <10 g/dL) childhood anemia. Maternal depression was assessed by the questionnaire PHQ-9. Odds ratios and their confidence intervals (CIs) were estimated by multinomial logistic regression models, considering the complex sample design. Setting: Peru Participants: Peruvian women of childbearing age from 15 to 49 years who live with children from 6 to 59 months. Results: Maternal depression was significantly associated with a higher odds of moderate/severe chronic undernutrition in children aged 6-59 months (OR = 2.67; 95% CI 1.16-6.16). Conclusions: There was evidence that maternal depression was associated with an increased risk of moderate/severe chronic undernutrition
- Open Access
- 13 March 2021
- Published by Romanian Society of Gastroenterology and Hepatology in Journal of Gastrointestinal and Liver Diseases
- Vol. 30 (1) , 110-121
Vasoactive Agents for the Management of Acute Variceal Bleeding: A Systematic Review and Meta-analysis
Background and Aims: Vasoactive agents with endoscopic therapy are used to treat acute variceal bleeding (AVB). There are two main groups of vasoactive agents: terlipressin and vasopressin (T-V), and octreotide and somatostatin (O-S). However, the benefit/harm balance is unclear. Our aim was to assess the efficacy and safety of T-V versus O-S for the management of AVB. Methods: We performed a systematic search for randomized controlled trials (RCTs) in PubMed, Scopus, and CENTRAL. Our main outcomes were mortality and adverse events. Secondary outcomes were bleeding control, rebleeding, blood transfusion, hospital stay. We evaluated the certainty of evidence using GRADE methodology. Results: We included 21 RCTs. The risk of mortality (RR: 1.01; 95%CI: 0.83-1.22), bleeding control (RR: 0.96; 95%CI: 0.91-1.02; I 2 =53%), early rebleeding (RR: 0.91; 95%CI: 0.66-1.24: I 2 =0%), late rebleeding (RR: 0.94; 95 CI: 0.56-1.60; I 2 =0%), blood transfusion (MD: 0.04; 95%CI: -0.31-0.39; I 2 =68%) and hospital stay (MD: -1.06; 95%CI: -2.80-0.69; I 2 =0%) were similar between T-V and O-S groups. Only 15 studies reported adverse events, which were significantly higher in the T-V compared to the O-S group (RR 2.39; 95%CI: 1.58-3.63; I 2 =57%). The certainty of evidence was moderate for the main outcomes, and low or very low for others. Conclusions: In cirrhotic patients with AVB, those treated with T-V had similar mortality risk compared to O-S. However, the use of T-V showed an increased risk of adverse events compared to O-S.
- 13 March 2021
- Published by Romanian Society of Gastroenterology and Hepatology in Journal of Gastrointestinal and Liver Diseases
- Vol. 30 (1) , 110-121
Open AccessVasoactive Agents for the Management of Acute Variceal Bleeding: A Systematic Review and Meta-analysis
Background and Aims: Vasoactive agents with endoscopic therapy are used to treat acute variceal bleeding (AVB). There are two main groups of vasoactive agents: terlipressin and vasopressin (T-V), and octreotide and somatostatin (O-S). However, the benefit/harm balance is unclear. Our aim was to assess the efficacy and safety of T-V versus O-S for the management of AVB. Methods: We performed a systematic search for randomized controlled trials (RCTs) in PubMed, Scopus, and CENTRAL. Our main outcomes were mortality and adverse events. Secondary outcomes were bleeding control, rebleeding, blood transfusion, hospital stay. We evaluated the certainty of evidence using GRADE methodology. Results: We included 21 RCTs. The risk of mortality (RR: 1.01; 95%CI: 0.83-1.22), bleeding control (RR: 0.96; 95%CI: 0.91-1.02; I 2 =53%), early rebleeding (RR: 0.91; 95%CI: 0.66-1.24: I 2 =0%), late rebleeding (RR: 0.94; 95 CI: 0.56-1.60; I 2 =0%), blood transfusion (MD: 0.04; 95%CI: -0.31-0.39; I 2 =68%) and hospital stay (MD: -1.06; 95%CI: -2.80-0.69; I 2 =0%) were similar between T-V and O-S groups. Only 15 studies reported adverse events, which were significantly higher in the T-V compared to the O-S group (RR 2.39; 95%CI: 1.58-3.63; I 2 =57%). The certainty of evidence was moderate for the main outcomes, and low or very low for others. Conclusions: In cirrhotic patients with AVB, those treated with T-V had similar mortality risk compared to O-S. However, the use of T-V showed an increased risk of adverse events compared to O-S.
- Open Access
- 1 February 2021
- Published by Universidad Nacional Mayor de San Marcos, Vicerectorado de Investigacion in Anales de la Facultad de Medicina
- Vol. 81 (4)
Avances en la investigación de enfermedades crónicas no transmisibles en el Perú
Las enfermedades no transmisibles (ENT) son causa importante de carga de enfermedad en el Perú así como en otros países en desarrollo. Las respuestas para el control de las ENT requieren de investigación multidisciplinaria, tanto a nivel local como internacional. Desde hace más de 10 años, CRONICAS: Centro de Excelencia en Enfermedades Crónicas, de la Universidad Peruana Cayetano Heredia, realiza investigación en el campo de las ENT en el Perú. En el presente artículo se describen algunos estudios realizados, incluyendo los estudios epidemiológicos PERU MIGRANT, y la cohorte CRONICAS. También se presentan resultados de revisiones sistemáticas y resultados de intervenciones frente a las ENT. A través de estos estudios llevados a cabo por el centro CRONICAS se señalan potenciales áreas para afrontar las ENT en países en desarrollo.
- 1 February 2021
- Published by Universidad Nacional Mayor de San Marcos, Vicerectorado de Investigacion in Anales de la Facultad de Medicina
- Vol. 81 (4)
Open AccessAvances en la investigación de enfermedades crónicas no transmisibles en el Perú
Las enfermedades no transmisibles (ENT) son causa importante de carga de enfermedad en el Perú así como en otros países en desarrollo. Las respuestas para el control de las ENT requieren de investigación multidisciplinaria, tanto a nivel local como internacional. Desde hace más de 10 años, CRONICAS: Centro de Excelencia en Enfermedades Crónicas, de la Universidad Peruana Cayetano Heredia, realiza investigación en el campo de las ENT en el Perú. En el presente artículo se describen algunos estudios realizados, incluyendo los estudios epidemiológicos PERU MIGRANT, y la cohorte CRONICAS. También se presentan resultados de revisiones sistemáticas y resultados de intervenciones frente a las ENT. A través de estos estudios llevados a cabo por el centro CRONICAS se señalan potenciales áreas para afrontar las ENT en países en desarrollo.